XML 132 R116.htm IDEA: XBRL DOCUMENT v3.25.3
Note 20 - Summary of Significant Accounting Policies - Revision of Previously Issued Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Accounts receivable, net of allowance for expected credit losses $ 142,181   $ 146,870 $ 152,259 $ 154,172    
Inventories 74,956 $ 80,847 75,150 74,970 71,320    
Prepaid expenses and other current assets 64,660 74,767 67,214 71,851 51,360    
Current assets held for sale 73,535   90,696 83,238 99,052    
Total current assets 708,339 678,343 710,371 847,843 833,031    
Total assets 2,059,582 2,019,000 2,034,015 2,042,771 2,100,265 $ 2,885,345  
Accrued compensation and benefits 35,799 32,018 26,336 28,541 29,216    
Accrued income taxes payable 9,416 8,771 10,243 6,852 9,085    
Total current liabilities 237,674 246,174 221,049 202,524 206,089    
Long-term deferred tax liabilities 18,245 20,322 22,314 18,969 18,184    
Total liabilities 332,596 345,979 338,564 322,602 332,418    
Accumulated other comprehensive loss (22,213) (19,921) (42,212) (55,262) (13,464)    
Retained earnings 1,419,956 1,369,081 1,417,065 1,464,727 1,475,719    
Total stockholders' equity 1,726,986 1,673,021 1,695,451 1,720,169 1,767,847 $ 2,534,107 $ 3,363,386
Total liabilities and stockholders' equity 2,059,582 2,019,000 2,034,015 2,042,771 2,100,265    
Other assets 6,115   7,100   10,670    
Noncurrent assets held for sale 85,006   133,303   173,794    
Accounts payable 37,722 38,321 39,272   33,344    
Noncurrent liabilities held for sale 14,291   31,026   42,196    
Additional paid-in capital $ 529,605 524,224     505,958    
Previously Reported [Member]              
Accounts receivable, net of allowance for expected credit losses     149,490 155,038 156,273    
Inventories   80,506 83,321 81,006 78,923    
Prepaid expenses and other current assets   75,243 67,590 72,140 75,456    
Current assets held for sale     79,754 72,573 88,894    
Total current assets   678,478 710,596 846,282 832,807    
Total assets   2,019,135 2,041,925 2,041,210 2,100,041    
Accrued compensation and benefits   31,540 26,039 28,405 27,785    
Accrued income taxes payable   8,847 10,321 6,931 9,266    
Total current liabilities   245,435 220,713 202,467 204,839    
Long-term deferred tax liabilities   20,583 22,458 18,668 18,084    
Total liabilities   345,501 340,433 322,244 331,074    
Accumulated other comprehensive loss   (19,635) (42,149) (55,237)      
Retained earnings   1,370,237 1,423,043 1,463,499 1,476,839    
Total stockholders' equity   1,673,634 1,701,492 1,718,966 1,768,967    
Total liabilities and stockholders' equity   2,019,135 2,041,925 2,041,210 2,100,041    
Other assets     7,125        
Noncurrent assets held for sale     140,963        
Accounts payable   37,984 39,155        
Noncurrent liabilities held for sale     33,087        
Additional paid-in capital   523,395          
Revision of Prior Period, Adjustment [Member]              
Accounts receivable, net of allowance for expected credit losses     (2,620) (2,779) (2,101)    
Inventories   341 (8,171) (6,036) (7,603)    
Prepaid expenses and other current assets   (476) (376) (289) (230)    
Current assets held for sale     10,942 10,665 10,158    
Total current assets   (135) (225) 1,561 224    
Total assets   (135) (7,910) 1,561 224    
Accrued compensation and benefits   478 297 136 1,431    
Accrued income taxes payable   (76) (78) (79) (181)    
Total current liabilities   739 336 57 1,250    
Long-term deferred tax liabilities   (261) (144) 301 100    
Total liabilities   478 (1,869) 358 1,344    
Accumulated other comprehensive loss   (286) (63) (25)      
Retained earnings   (1,156) (5,978) 1,228 (1,120)    
Total stockholders' equity   (613) (6,041) 1,203 (1,120)    
Total liabilities and stockholders' equity   (135) (7,910) $ 1,561 $ 224    
Other assets     (25)        
Noncurrent assets held for sale     (7,660)        
Accounts payable   337 117        
Noncurrent liabilities held for sale     $ (2,061)        
Additional paid-in capital   $ 829